Your browser doesn't support javascript.
loading
Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin-deficient and mdx mice.
White, Zoe; Theret, Marine; Milad, Nadia; Tung, Lin Wei; Chen, William Wei-Han; Sirois, Martin G; Rossi, Fabio; Bernatchez, Pascal.
  • White Z; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia (UBC), Vancouver, BC, Canada.
  • Theret M; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
  • Milad N; School of Biomedical Engineering, Department of Medical Genetics, University of British Columbia (UBC), Vancouver, BC, Canada.
  • Tung LW; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia (UBC), Vancouver, BC, Canada.
  • Chen WW; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
  • Sirois MG; School of Biomedical Engineering, Department of Medical Genetics, University of British Columbia (UBC), Vancouver, BC, Canada.
  • Rossi F; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia (UBC), Vancouver, BC, Canada.
  • Bernatchez P; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
J Cachexia Sarcopenia Muscle ; 13(1): 544-560, 2022 02.
Article en En | MEDLINE | ID: mdl-34927367
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atrofia Muscular / Músculo Esquelético / Ezetimiba / Disferlina Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atrofia Muscular / Músculo Esquelético / Ezetimiba / Disferlina Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article